92 related articles for article (PubMed ID: 6240574)
21. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
Löwenberg M; Verhaar AP; van den Brink GR; Hommes DW
Trends Mol Med; 2007 Apr; 13(4):158-63. PubMed ID: 17293163
[TBL] [Abstract][Full Text] [Related]
22. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications.
Elenkov IJ; Papanicolaou DA; Wilder RL; Chrousos GP
Proc Assoc Am Physicians; 1996 Sep; 108(5):374-81. PubMed ID: 8902882
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid hormones upregulate interleukin 2 receptor alpha gene expression.
Lamas M; Sanz E; Martin-Parras L; Espel E; Sperisen P; Collins M; Silva AG
Cell Immunol; 1993 Oct; 151(2):437-50. PubMed ID: 8402947
[TBL] [Abstract][Full Text] [Related]
24. Limiting dilution analysis of interleukin 2 and colony-stimulating factor producer cells in normal and autoimmune mice.
Hefeneider SH; Conlon PJ; Dower SK; Henney CS; Gillis S
J Immunol; 1984 Apr; 132(4):1863-8. PubMed ID: 6607951
[TBL] [Abstract][Full Text] [Related]
25. IL-1 as a self-serving principle in T-cell clones.
Durum SK; Brody DT; Tartakovsky B
Ann Inst Pasteur Immunol; 1987; 138(3):469-72. PubMed ID: 2958017
[No Abstract] [Full Text] [Related]
26. Interleukin 1: an immunological perspective.
Durum SK; Schmidt JA; Oppenheim JJ
Annu Rev Immunol; 1985; 3():263-87. PubMed ID: 2933048
[No Abstract] [Full Text] [Related]
27. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity.
Chuchawankul S; Shima M; Buckley NE; Hartmann CB; McCoy KL
Int Immunopharmacol; 2004 Feb; 4(2):265-78. PubMed ID: 14996418
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-independent activation of helper T cells. I. Production of Interleukin 2.
Farrar JJ; Mizel SB; Fuller-Farrar J; Farrar WL; Hilfiker ML
J Immunol; 1980 Aug; 125(2):793-8. PubMed ID: 6967089
[No Abstract] [Full Text] [Related]
29. Biology and biochemistry of T cell-derived lymphokines. I. The coordinate synthesis of interleukin 2 and colony-stimulating factors in a murine T cell lymphoma.
Watson JD
J Immunol; 1983 Jul; 131(1):293-7. PubMed ID: 6602832
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid inhibitory action on the response to PHA of residual circulatory lymphocytes in renal transplant patients following immunosuppressive therapy.
Musiani P; Citterio F; Maggiano N; Pozzetto U; Lauriola L; Luciani G; Ranelletti FO; Castagneto M; Piantelli M
Clin Exp Immunol; 1984 Jan; 55(1):217-23. PubMed ID: 6362935
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
Yano A; Fujii Y; Iwai A; Kageyama Y; Kihara K
Clin Cancer Res; 2006 May; 12(10):3003-9. PubMed ID: 16707595
[TBL] [Abstract][Full Text] [Related]
32. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
33. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
34. [Interleukins as modulators of the immune system].
Röllinghoff M
Ric Clin Lab; 1984; 14 Suppl 2():15-20. PubMed ID: 6241743
[No Abstract] [Full Text] [Related]
35. [The role of interleukin-2 during the activation of cytotoxic T-lymphocytes].
Solbach W; Röllinghoff M; Wagner H
Klin Wochenschr; 1983 Jan; 61(2):67-75. PubMed ID: 6221151
[No Abstract] [Full Text] [Related]
36. Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.
Moore RN; Oppenheim JJ; Farrar JJ; Carter CS; Waheed A; Shadduck RK
J Immunol; 1980 Sep; 125(3):1302-5. PubMed ID: 6774016
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes.
Baus E; Andris F; Dubois PM; Urbain J; Leo O
J Immunol; 1996 Jun; 156(12):4555-61. PubMed ID: 8648096
[TBL] [Abstract][Full Text] [Related]
38. Regulation of sialoadhesin expression on rat macrophages. Induction by glucocorticoids and enhancement by IFN-beta, IFN-gamma, IL-4, and lipopolysaccharide.
van den Berg TK; van Die I; de Lavalette CR; Döpp EA; Smit LD; van der Meide PH; Tilders FJ; Crocker PR; Dijkstra CD
J Immunol; 1996 Oct; 157(7):3130-8. PubMed ID: 8816424
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticosteroid response-modifying factors derived from accessory cells.
Mishell RI; Bradley LM; Chen YH; Grabstein KH; Shiigi SM
Ann N Y Acad Sci; 1979; 332():433-45. PubMed ID: 316982
[No Abstract] [Full Text] [Related]
40. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation.
Brewer JA; Khor B; Vogt SK; Muglia LM; Fujiwara H; Haegele KE; Sleckman BP; Muglia LJ
Nat Med; 2003 Oct; 9(10):1318-22. PubMed ID: 12949501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
